2025
Meditation training in older adults has been proposed as a non-pharmacological intervention to promote healthy aging and lower the risks (…)
Consulter 
2025
Recombinant tissue plasminogen activator (alteplase) and its derivative tenecteplase are approved for acute ischemic stroke (AIS), but their low recanalization (…)
Consulter
2025
Ischemic stroke, a leading cause of death and disability worldwide, arises predominantly from atherosclerosis and thromboembolic occlusion of cerebral arteries. (…)
Consulter
2025
Monitoring immune reactions via inflammation imaging provides valuable disease prognosis but remains limited by the currently available probes and imaging (…)
Consulter
2025
Hippocampal subfields differentially develop and age, and they vary in vulnerability to neurodegenerative diseases. Innovation in high-resolution imaging has accelerated (…)
Consulter
2025
Meditation practice has been shown to impact resting-state EEG activity in expert meditators, but its benefits on sleep, which is (…)
Consulter
